SCHEMBL6178185

SCHEMBL6178185

CCc1ccc(C2CCCN2S(=O)(=O)c2ccc(C)c(O)c2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 3/20 0.53
KDM4E B2RXH2 1/20 0.44
RXFP1 Q9HBX9 1/20 0.44
NR3C2 P08235 1/20 0.43
FKBP1A P62942 4/20 0.43
PSEN1 P49768 1/20 0.42
PSEN2 P49810 1/20 0.42
APH1B Q8WW43 1/20 0.42
NCSTN Q92542 1/20 0.42
APH1A Q96BI3 1/20 0.42
PSENEN Q9NZ42 1/20 0.42
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
LOXL2 Q9Y4K0 2/20 0.40
POLB P06746 1/20 0.39
MAPT P10636 1/20 0.39
HSD11B1 P28845 1/20 0.39
HCRTR1 O43613 1/20 0.39
HCRTR2 O43614 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6179184 0.89 TRPA1 (0.57) TRPA1KDM4ENR3C2PSEN1PSEN2
SCHEMBL6178979 0.86 PSEN1 (0.57) TRPA1NR3C2PSEN1PSEN2APH1B
SCHEMBL6178178 0.83 TRPA1 (0.61) TRPA1NR3C2FKBP1APSEN1PSEN2
SCHEMBL6178182 0.83 TRPA1 (0.61) TRPA1NR3C2FKBP1APSEN1PSEN2
SCHEMBL6180591 0.81 TRPA1 (0.48) TRPA1KDM4ENR3C2PSEN1PSEN2
SCHEMBL6178582 0.80 PSEN1 (0.65) TRPA1FKBP1APSEN1PSEN2APH1B
SCHEMBL6178575 0.80 PSEN1 (0.65) TRPA1FKBP1APSEN1PSEN2APH1B
SCHEMBL6177734 0.80 TRPA1 (0.80) TRPA1KDM4EFKBP1APSEN1PSEN2
SCHEMBL6177742 0.80 TRPA1 (0.80) TRPA1KDM4EFKBP1APSEN1PSEN2
SCHEMBL6177461 0.80 TRPA1 (0.80) TRPA1KDM4EFKBP1APSEN1PSEN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1165510-B1 1-ARENESULFONYL-2-ARYL-PYRROLIDINE AND PIPERIDINE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS HOFFMANN LA ROCHE (CH) 2005-09-28 EP claimed